-
The authors of this unsigned editorial were not amused when John Reid, the minister of health for England and Wales, charged the National Health Service hospitals with reducing by half the number of methicillin-resistant Staphylococcus aureus (MRSA) infections by 2008.
-
Although proton pump inhibitors (PPIs) are considered to be among the safest of drugs, this study suggests that PPIs increase the risk of development of C. difficile-related diarrhea among hospitalized patients.
-
While respirator fit-testing has been the most controversial issue, infection control professionals should be aware that a new tuberculosis risk-assessment strategy is outlined in draft TB guidelines by the Centers for Disease Control and Prevention (CDC).
-
Nearly two-thirds of new HIV infections in the United States are transmitted by people who do not know they have the disease. A growing array of rapid HIV tests is changing this longstanding problem, providing results in as little as 20 minutes that can help prevent transmission and get those unknowingly infected into treatment.
-
Reporting unused vaccine in some areas, the Centers for Disease Control and Prevention is letting up the reins and opening supplies to other risk groups. The priority groups remain the same, but others as described here can be immunized if supplies are adequate.
-
A most unusual flu season has taken another strange turn, as a national flu vaccine shortage that once dominated headlines and sparked exchanges in the presidential campaign has given way to consumer apathy and supply surpluses in some states. Instead of people lined up outside clinics, there are rows of flu vaccine vials sitting unused in cold storage.
-
Conceding hard-fought ground, the Occupational Safety and Health Administration (OSHA) has ordered its inspectors to stand down on the controversial issue of annual respirator fit-testing for health care workers occupationally exposed to tuberculosis.
-
-
The Use of Prophylactic Antibiotics for Neutropenia; Is It Hot In Here?; Homeopathy vs Conventional Medicine; FDA Actions
-